Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Victor Khor"'
Autor:
Venkatesh Krishnan, Ching-Wei Chang, Habib Hamidi, Michael A. Bookman, Charles Landen, Tashanna Myers, Hiroaki Kajiyama, Sakari Hietanen, Lyndsay Willmott, Premal Thaker, Cagatay Taskiran, Jalid Sehouli, Victor Khor, Yvonne Lin Liu, Sandro Pignata, Kathleen Moore, Luciana Molinero
Publikováno v:
Cancer Research. 83:5702-5702
Background: Tumor biomarkers such as CD8 density and location (i.e., immune inflamed phenotype) and immune rich molecular subtype have been linked to immune checkpoint blockade (ICB) overall survival (OS) in different cancers. The IMagyn050 trial (NC
Autor:
Luciana Molinero, Christopher J. Darus, Xiaohua Wu, Johanna Mäenpää, Charles K. Anderson, Nicoletta Colombo, Aikou Okamoto, Giovanni Scambia, Y. García, Fan Wu, Michael A. Bookman, Yvonne G. Lin, Victor Khor, L. Willmott, Jalid Sehouli, Tashanna Myers, Michalis Liontos, Rustem Safin, Michael A. Gold, Cagatay Taskiran, Katina Robison, Austin Miller, Vidya Maiya, Sudarshan K. Sharma, Carol Aghajanian, Sandro Pignata, Jessica Thomes-Pepin, Kathleen N. Moore
Publikováno v:
J Clin Oncol
Journal of Clinical Oncology
Journal of Clinical Oncology
Purpose: to evaluate the addition of the humanized monoclonal antiprogrammed death ligand-1 (PD-L1) antibody, atezolizumab, to platinum-based chemotherapy and bevacizumab in newly diagnosed stage III or IV ovarian cancer (OC). Methods: this multicent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ea89f9ab83f69d1132450dbd7ec3832
http://hdl.handle.net/10281/327598
http://hdl.handle.net/10281/327598
Autor:
Victor Khor, Charles N. Landen, Cagatay Taskiran, Michael A. Bookman, Regina Berger, Kristina Lindemann, Thomas Reid, Luciana Molinero, Austin Miller, Fan Wu, Mario E. Beiner, Aikou Okamoto, Yvonne G. Lin, Stephanie V. Blank, Jalid Sehouli, Carol Aghajanian, Premal H. Thaker, Charles K. Anderson, Sandro Pignata, Kathleen N. Moore, Andrew Green, Tashanna Myers, Els Van Nieuwenhuysen
Publikováno v:
Gynecologic Oncology. 162:S37-S38
Objectives: Genomically unstable tumors, characterized by BRCA1/2 alterations and homologous recombination deficiency (HRD), are hypothesized to be more mutated and potentially more sensitive to immune checkpoint inhibitors. To explore this hypothesi
Autor:
Paolo Zola, Victor Khor, Yvonne G. Lin, David Cibula, Katherine M. Moxley, Charles K. Anderson, Alain Lortholary, Joseph Buscema, Sheetal Patel, Mary J Scroggins, Giorgia Mangili, Tashanna Myers, Austin Miller, Kathleen N. Moore, Fan Wu, Richard T. Penson, Michael A. Bookman, Flora Zagouri, Katina Robison, Radoslaw Madry, Lari Wenzel, Frederick R. Ueland, Ana Herrero
Publikováno v:
Gynecologic Oncology. 162:S229-S230
Objectives: Although primary results from the IMagyn050 trial showed no statistically significant improvement in progression-free survival (PFS) with atezo added to carboplatin/paclitaxel/bevacizumab (CPB) [Moore, ESMO 2020], the impact of this regim
Autor:
Giovanni Scambia, Kathleen N. Moore, Salvatore Antonio Pignata, Nicoletta Colombo, Luciana Molinero, K. Robison, Carol Aghajanian, Johanna Mäenpää, Anthony B. Miller, Charles K. Anderson, Michael A. Bookman, L.J. Willmott, J. Thomes-Pepin, Victor Khor, M.A. Gold, Tashanna Myers, Yvonne G. Lin, F. Wu, Jalid Sehouli, Cagatay Taskiran
Publikováno v:
Annals of Oncology. 31:S1161-S1162